
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €145.6m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.50
7D
-5.2%
1Y
-13.0%
argenx
Market Cap: €37.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€601.20
7D
0.2%
1Y
10.2%